Beacon Medical Group, INC.
Beacon Medical Group, INC. was paid $3.38M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 27% of everything it billed.
LA PORTE, IN 46350
Next to other Obstetrics & Gynecology Physician providers in Indiana
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,997 | $150K | |
| 2019 | 22,557 | $232K | |
| 2020 | 21,336 | $183K | |
| 2021 | 49,047 | $793K | |
| 2022 | 47,211 | $926K | |
| 2023 | 61,437 | $731K | |
| 2024incomplete | 43,416 | $367K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 27% | 10,644 | 7,180 | $899K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 7,059 | 6,195 | $391K |
| 80050 | General health panel | 10% | 7,276 | 6,787 | $339K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.2% | 9,586 | 8,747 | $176K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.5% | 18,091 | 16,672 | $151K |
| 80053 | Comprehensive metabolic panel | 4.3% | 27,683 | 25,413 | $146K |
| 80061 | Lipid panel | 4.3% | 20,854 | 18,964 | $144K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.2% | 3,016 | 2,660 | $109K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.0% | 23,812 | 21,746 | $101K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.0% | 16,666 | 15,236 | $100K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.7% | 3,540 | 3,184 | $92K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.6% | 4,706 | 4,365 | $87K |
73 more codes
| 82728 | 1.6% | 5,398 | $55K | |
| 84439 | 1.6% | 8,863 | $55K | |
| 85027 | 1.5% | 12,091 | $49K | |
| 86803 | 1.0% | 3,258 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 8,430 | $35K |
| 82607 | <1% | 2,961 | $26K | |
| 83970 | <1% | 1,311 | $25K | |
| 86762 | <1% | 1,965 | $24K | |
| 83550 | <1% | 3,661 | $23K | |
| 86140 | <1% | 5,163 | $18K | |
| 87340 | <1% | 2,301 | $18K | |
| 82570 | <1% | 6,262 | $18K | |
| 82043 | <1% | 5,642 | $17K | |
| 83540 | <1% | 3,732 | $17K | |
| 84153 | <1% | 1,286 | $15K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,460 | $15K |
| 81001 | <1% | 6,650 | $13K | |
| 86592 | <1% | 3,920 | $13K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 282 | $12K |
| 82950 | <1% | 3,283 | $12K | |
| 83735 | <1% | 3,167 | $11K | |
| 84702 | <1% | 1,015 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,372 | $11K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 155 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 200 | $8K |
| 85652 | <1% | 4,107 | $8K | |
| 83880 | <1% | 392 | $8K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 212 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 212 | $7K |
| 84481 | <1% | 455 | $6K | |
| 84403 | <1% | 243 | $5K | |
| 84460 | <1% | 1,288 | $5K | |
| 80069 | <1% | 1,257 | $5K | |
| 83001 | <1% | 221 | $4K | |
| 84550 | <1% | 1,251 | $4K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 383 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 88 | $3K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 103 | $3K |
| 87088 | <1% | 738 | $3K | |
| 87186 | <1% | 731 | $3K | |
| 80076 | <1% | 459 | $3K | |
| 82565 | <1% | 802 | $3K | |
| 84100 | <1% | 1,001 | $3K | |
| 85610 | <1% | 945 | $3K | |
| 86431 | <1% | 573 | $3K | |
| 84156 | <1% | 624 | $2K | |
| 83690 | <1% | 355 | $2K | |
| 82746 | <1% | 135 | $1K | |
| 83721 | <1% | 370 | $1K | |
| 90682 | <1% | 32 | $1K | |
| 84450 | <1% | 231 | $1K | |
| 93000 | <1% | 113 | $920.65 | |
| 86376 | <1% | 67 | $844.14 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 210 | $815.96 |
| 82550 | <1% | 109 | $519.67 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 54 | $481.56 |
| 83002 | <1% | 25 | $442.09 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 26 | $375.42 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 18 | $358.82 |
| 86780 | <1% | 29 | $331.44 | |
| 73630 | <1% | 23 | $319.16 | |
| 11721 | <1% | 46 | $290.48 | |
| 86800 | <1% | 14 | $167.27 | |
| 82951 | <1% | 13 | $155.47 | |
| 86160 | <1% | 14 | $101.55 | |
| 11720 | <1% | 12 | $99.90 | |
| 86141 | <1% | 13 | $58.75 | |
| 82952 | <1% | 13 | $47.35 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 33 | $4.85 |
| 0352U | 0% | 94 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 13 | $0.00 |
| 90688 | 0% | 40 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Memorial Hospital of South Bend | South Bend, IN | $33.19M |
| Elkhart General Hospital, INC. | Elkhart, IN | $25.59M |
| Beacon Medical Group, INC. | Granger, IN | $7.19M |
| Beacon Medical Group, INC. | South Bend, IN | $4.76M |
| Beacon Medical Group, INC. | South Bend, IN | $4.65M |
| Beacon Medical Group, INC. | Elkhart, IN | $4.64M |
| Beacon Medical Group, INC. | South Bend, IN | $4.44M |
| Beacon Medical Group, INC. | Elkhart, IN | $2.45M |
| Beacon Medical Group, INC. | Granger, IN | $2.11M |
| Beacon Medical Group, INC. | South Bend, IN | $1.53M |
| Memorial Hospital of South Bend | Granger, IN | $1.34M |
| Beacon Medical Group, INC. | South Bend, IN | $1.09M |
| Beacon Medical Group, INC. | South Bend, IN | $1.07M |
| Beacon Medical Group, INC. | Elkhart, IN | $953K |
| Beacon Medical Group, INC. | South Bend, IN | $872K |
| Beacon Medical Group, INC. | Mishawaka, IN | $836K |
| Beacon Medical Group, INC. | Elkhart, IN | $758K |
| Beacon Health, LLC | Granger, IN | $733K |
| Beacon Medical Group, INC. | Mishawaka, IN | $727K |
| Beacon Medical Group, INC. | Bristol, IN | $725K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.